Sophie Laurent
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sophie Laurent has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
Angelo Paci
Gustave Roussy, Pharmacol Dept, Villejuif, France
1 shared publication- Anouchka Seesaghur
Centre for Observational Research, Amgen Ltd, Uxbridge, UK
1 shared publication Arthur Geraud
Inst Paoli Calmette, Dept Med Oncol, Marseille, France
1 shared publication- Barry Quinn
Queen’s University Belfast, Belfast, UK
1 shared publication C. Lemarec
Institut Gustave-Roussy, Villejuif, France
1 shared publicationCelia Lloret-Linares
Ramsay Sante Hop Prive Pays Savoie, Annemasse, France
1 shared publication
Latest Publications
- 2 February 2024
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 67 (6) , e859-e868
Management of Pain Medication in Patients With a History of Bariatric Surgery: A Systematic Review
- 2 February 2024
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 67 (6) , e859-e868
Management of Pain Medication in Patients With a History of Bariatric Surgery: A Systematic Review
- Open Access
- 6 December 2021
- Published by Taylor & Francis in Pain Management
- Vol. 12 (4) , 435-446
The Managing Advanced Cancer Pain Together (MACPT) Conversation Tool: An Evaluation of use in Clinical Practice
Aim: To investigate use of the ‘Managing Advanced Cancer Pain Together’ conversation tool between individuals with advanced cancer and healthcare professionals (HCPs) during routine consultations. ... Lay abstract The Managing Advanced Cancer Pain Together conversation tool was designed to help patients with advanced cancer and their healthcare professionals (HCPs) discuss various aspects of pai...
- 6 December 2021
- Published by Taylor & Francis in Pain Management
- Vol. 12 (4) , 435-446
Open AccessThe Managing Advanced Cancer Pain Together (MACPT) Conversation Tool: An Evaluation of use in Clinical Practice
Aim: To investigate use of the ‘Managing Advanced Cancer Pain Together’ conversation tool between individuals with advanced cancer and healthcare professionals (HCPs) during routine consultations. ... Lay abstract The Managing Advanced Cancer Pain Together conversation tool was designed to help patients with advanced cancer and their healthcare professionals (HCPs) discuss various aspects of pai...
- Open Access
- 1 October 2018
- Published by Taylor & Francis in Journal of Pain Research
- Vol. ume 11, 2587-2601
Practical management of opioid rotation and equianalgesia
Purpose: To review the recent literature on opioid rotation (ie, switching from one opioid drug to another or changing an opioid’s administration route) in cancer patients experiencing severe pain and to develop a novel equianalgesia table for use in routine clinical practice. Methods: The MEDLINE database was searched with terms “cancer pain,” “opioid rotation,” “opioid switching,” “opioid ratio,” “opioid conversion ratio,” and “opioid equianalgesia” for the major opioids (morphine, oxycodone, fentanyl, and hydromorphone) and the intravenous, subcutaneous, oral, and transdermal administration routes. Selected articles were assessed for the calculated or cited opioid dose ratio, bidirectionality, and use of the oral morphine equivalent daily dose or a direct drug-to-drug ratio. Results: Twenty publications met our selection criteria and were analyzed in detail. We did not find any large-scale, prospective, double-blind randomized controlled trial with robust design, and most of the studies assessed relatively small numbers of patients. Bidirectionality was investigated in seven studies only. Conclusion: The updated equianalgesic table presented here incorporates the latest data and provides information on bidirectionality. Despite the daily use of equianalgesic tables, they are not based on high-level scientific evidence. More clinical research is needed on this topic.
- 1 October 2018
- Published by Taylor & Francis in Journal of Pain Research
- Vol. ume 11, 2587-2601
Open AccessPractical management of opioid rotation and equianalgesia
Purpose: To review the recent literature on opioid rotation (ie, switching from one opioid drug to another or changing an opioid’s administration route) in cancer patients experiencing severe pain and to develop a novel equianalgesia table for use in routine clinical practice. Methods: The MEDLINE database was searched with terms “cancer pain,” “opioid rotation,” “opioid switching,” “opioid ratio,” “opioid conversion ratio,” and “opioid equianalgesia” for the major opioids (morphine, oxycodone, fentanyl, and hydromorphone) and the intravenous, subcutaneous, oral, and transdermal administration routes. Selected articles were assessed for the calculated or cited opioid dose ratio, bidirectionality, and use of the oral morphine equivalent daily dose or a direct drug-to-drug ratio. Results: Twenty publications met our selection criteria and were analyzed in detail. We did not find any large-scale, prospective, double-blind randomized controlled trial with robust design, and most of the studies assessed relatively small numbers of patients. Bidirectionality was investigated in seven studies only. Conclusion: The updated equianalgesic table presented here incorporates the latest data and provides information on bidirectionality. Despite the daily use of equianalgesic tables, they are not based on high-level scientific evidence. More clinical research is needed on this topic.
- 31 August 2017
- Published by Morressier GmbH
AUDIT OF COMPREHENSIVE CANCER CENTRES PAIN UNITS IN FRANCE
- 31 August 2017
- Published by Morressier GmbH
AUDIT OF COMPREHENSIVE CANCER CENTRES PAIN UNITS IN FRANCE